CAS: 2007885-39-2
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | PAT-1251 REF: 3D-HFD88539CAS: 2007885-39-2 | Min. 95% | A consultar | Lun 02 Dic 24 |
 | PAT-1251 REF: TM-T12371LCAS: 2007885-39-2 | 99.49% - 99.78% | 183,00 €~3.709,00 € | Mar 10 Dic 24 |
PAT-1251
CAS:2007885-39-2
PAT-1251 is a lysine-based anti-cancer drug that has been shown to be safe and effective …
Fórmula:
C18H17F4N3O3
Pureza:
Min. 95%
Peso molecular:
399.3 g/mol
Ref: 3D-HFD88539
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 2 de Diciembre de 2024
PAT-1251
CAS:2007885-39-2
PAT-1251 is an inhibitor of LOXL2 with IC50s of 10, 0.12, and 0.16 μM for …
Fórmula:
C18H17F4N3O3
Pureza:
99.49% - 99.78%
Forma y color:
Solid
Peso molecular:
399.34
Ref: TM-T12371L
| 1mg | 183,00 € | ||
| 1ml | 517,00 € | ||
| 5mg | 462,00 € | ||
| 10mg | 672,00 € | ||
| 25mg | 1.049,00 € | ||
| 50mg | 1.412,00 € | ||
| 100mg | 1.838,00 € | ||
| 500mg | 3.709,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
